What do systematic reviews say?

Intervention not reported

The review found no eligible studies for this question.

• Momordica charantia for type 2 diabetes mellitus 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression 2012 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 153 participants
  Low

Intervention not reported

• Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression 2012 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 784 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Green tea for weight loss and weight maintenance in overweight or obese adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Colesevelam for type 2 diabetes mellitus 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Interventions for latent autoimmune diabetes (LADA) in adults 2011 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus 2008 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus 2008 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sunitinib vs avelumab + axitinib (targeted agent versus immunotherapy + targeted agent)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sunitinib vs pembrolizumab + axitinib (targeted agent versus immunotherapy + targeted agent)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sunitinib vs IMA901 + sunitinib (targeted agent versus tumour vaccine + targeted agent)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sorafenib vs sunitinib (targeted agent versus targeted agent)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Bevacizumab + IFN vs IFN (+ placebo) (targeted agent + classic immunotherapy versus classic immunotherapy)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Temsirolimus + bevacizumab vs bevacizumab + IFN‐α (targeted agent + targeted agent versus targeted agent + classic immunotherapy)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Everolimus + bevacizumab vs bevacizumab + IFN‐α (targeted agent + targeted agent versus targeted agent + classic immunotherapy)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and improve… 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 4687 participants
  Very low

Vasopressin receptor antagonists vs placebo or no treatment

• Interventions for chronic non‐hypovolaemic hypotonic hyponatraemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 297 participants
  Very low

Exercise‐based cardiac rehabilitation vs usual care

• Exercise‐based cardiac rehabilitation for adults with stable angina 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 94 participants
  Very low

Intervention not reported

• Vitamin D supplementation for prevention of mortality in adults 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 105 participants
  GRADE not reported